CN Patent

CN101193652A — 包含肠降血糖素肽和非质子极性溶剂的药物制剂

Assigned to Amylin Pharmaceuticals LLC · Expires 2008-06-04 · 18y expired

What this patent protects

本公开内容涉及稳定的药物制剂及其用途。

USPTO Abstract

本公开内容涉及稳定的药物制剂及其用途。

Drugs covered by this patent

Glucagen (GLUCAGON) · Xeris

Patent Metadata

Patent number: CN101193652A
Jurisdiction: CN
Classification: —
Expires: 2008-06-04
Drug substance claim: No
Drug product claim: No
Assignee: Amylin Pharmaceuticals LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.